23andme

By Aditi Pai 11:23 am October 22, 2015
Almost two years after the FDA first told 23andMe to halt sales on its mail-order direct-to-consumer genetic testing service for disease risks, the company has relaunched a version of its new Personal Genome Service (PGS), which now meets FDA standards. “We’ve worked with the FDA for nearly two years to establish a regulatory path for direct-to-consumer genetic testing," 23andMe CEO Anne Wojcicki...
By Aditi Pai 09:32 am October 15, 2015
Mail-order personal genetics service and research company 23andMe has completed a $115 million in a round led by Fidelity Management and Research Company with participation from  Casdin Capital, WuXi Healthcare Ventures, and Xfund, as well as existing investors Illumina, New Enterprise Associates, MPM Capital, and Google Ventures. Part of this funding round was disclosed earlier this year when...
By Brian Dolan 08:20 am August 17, 2015
Practice Fusion's Ryan Howard (right) and MobiHealthNews' Jonah Comstock at Health 2.0 2014 (Source: Health 2.0) Practice Fusion announced that its CEO and founder Ryan Howard will step back away from the helm of the cloud-based EHR company, but will stay on as the company's board chairman. Tom Langan, Practice Fusion's chief commercial officer, will become the company's interim CEO. According...
By Jonah Comstock 05:02 am July 16, 2015
Ancestry.com, one of the biggest sites for genealogy in the world, is getting into health. The company officially launched a new website, AncestryHealth.com, in beta today and announced the hire of a Chief Health Officer, Dr. Cathy A. Petti, who has previously held executive roles at HealthSpring Global, TriCore Reference Laboratories, and Novartis. “Ancestry fundamentally believes family history...
By Jonah Comstock 09:34 am July 6, 2015
According to an SEC filing, mail-order personal genome service and research company 23andMe has raised $79 million, in a round the company hopes will top out at $150 million. The investors are undisclosed and 23andMe declined to comment while the round was ongoing. This is the company's largest single funding raise to date. It brings its total funding to $190 million plus a $1.4 million research...
By Aditi Pai 06:19 am June 17, 2015
San Francisco-based video visits company Doctor On Demand raised $50 million in a round led by Tenaya Capital with participation from new investors Qualcomm Ventures, Dignity Health, and 23andMe CEO Anne Wojcicki. Existing investors, Venrock, Shasta Ventures, and Sir Richard Branson also contributed. Doctor On Demand has raised more than $74 million in funding to date. Doctor On Demand offers its...
By Aditi Pai 11:05 am May 19, 2015
Jawbone's UP2 device Some 20 percent of investors said they expect Jawbone to go public this year, according to a Rock Health survey of 43 investors. Jawbone has raised an estimated $725 million, the seed fund reported. Rock Health released the survey just a few weeks after activity tracker company Fitbit filed the initial paperwork that puts it on the path for an IPO. In the company's filing...
By Jonah Comstock 07:46 am December 2, 2014
Google-backed 23andMe is finally relaunching its mail-order personal genome service -- just not in the United States. Instead, the company is launching in England, which has a different regulatory framework than the United States. "These products are considered to be in the lowest risk category and so there is no requirement for any premarket assessment," a spokesperson for the Medications and...
By Jonah Comstock 10:33 am November 10, 2014
Google's genomics browser, from a video the company released last year. Between contact lenses for diabetes, big data baseline health studies, and a tiny pill that scans for cancer (not to mention curing death and setting up telemedicine visits based on search results), Google is casting a wide net in the health care field. But the company's biggest contributions might come in an area where...
By Jonah Comstock 07:07 am July 28, 2014
Once again, Google has captured the news cycle with the announcement of an ambitious, health-focused project. But although Google's health portfolio continues to grow, its handful of health projects are still little more than pet projects to the search giant. As reported last week by The Wall Street Journal, the Google Baseline study will use a combination of genetic testing and digital health...